TFSA Investors: 2 U.S. Stocks I’m Never Selling

Canadians looking to diversify their portfolios and gain exposure to U.S. stocks can purchase shares of high-growth companies such as The Trade Desk and benefit from exponential gains.

| More on:

The Tax-Free Savings Account (TFSA) is a popular registered account among Canadians. Launched in 2009, the TFSA encourages savings and investments, as any withdrawal from the account is exempt from Canada Revenue Agency taxes.

Canadians can hold several asset classes in a TFSA that include stocks, bonds, and mutual funds. Investors can also buy and hold equities from exchanges south of the border, to further diversify their portfolio.

Here, we look at two U.S. stocks that I believe should be a part of your TFSA portfolio in 2022.

Green Thumb Industries

The first stock on my list is Green Thumb Industries (CNSX:GTII), a U.S.-based cannabis producer valued at a market cap of US$3 billion. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities and 77 retail locations across 15 states in the U.S.

The company manufactures and distributes a portfolio of branded cannabis products. It also owns and operates a chain of retail cannabis stores called RISE, which is fast gaining traction across the country.

Due to the recent wave of legalization in the U.S., Green Thumb has managed to increase sales from US$62.5 million in 2018 to US$893.56 million in 2021. In Q2, its sales rose by 14.6% year-over-year to US$254.3 million. It has now reported eight consecutive quarters of positive GAAP (generally accepted accounting principles) net income which stood at US$24.4 million or US$0.10 per diluted share in the June quarter.

Green Thumb’s adjusted operating EBITDA (earnings before interest, tax, depreciation, and amortization) rose 17.4% to US$78.7 million in Q2, accounting for 31% of sales. In the first six months of 2022, its operating cash flow stood at US$40 million.

Analysts also expect company sales to touch US$1.6 billion in 2023, valuing the stock at a forward price to sales multiple of 2.

Green Thumb stock is down 73% from all-time highs. But its now trading at a discount of 170% compared to consensus price target estimates. Now would be a good time to consider Green Thumb stock.

The Trade Desk

One of the largest players in the programmatic advertising segment, The Trade Desk (NASDAQ:TTD) is a solid long-term bet. Down 50% from all-time highs, TTD’s stock price has still surged 1,700% since its IPO in 2016.

Several tech giants such as Meta Platforms, Snap, and Twitter reported revenue and earnings below consensus estimates in Q2 due to a challenging macro-economic environment. However, The Trade Desk’s sales rose 35% year-over-year in Q2 to US$377 million while adjusted earnings surged 11% to US$0.20 per share. Analysts forecast sales and EPS (earnings per share) at US$365 million and US$0.20 per share, respectively.

TTD’s co-founder and CEO Jeff Green commented that the company’s stellar performance in Q2 provides the management team with confidence in gaining market share across economic cycles. It also continues to invest in verticals such as identity, connected TV, retail media, and supply chain optimization.

The Trade Desk has signed several partnerships with the world’s leading broadcasters, retailers, and publishers which should drive future revenue growth.

TTD now expects revenue of US$385 million and adjusted EBITDA of US$140 million in Q3. Analysts tracking TTD stock, forecast sales to touch US$382.2 million in the September quarter.

Due to the recent sell-off, TTD stock price is trading at a discount of almost 50% compared to consensus price target estimates. Considering its future growth potential, this stock offers a great opportunity to diversify your TFSA portfolio.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends The Trade Desk. The Motley Fool recommends Green Thumb Industries.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »